INOGEN, INC. (NASDAQ:INGN) Files An 8-K Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition
On January 9, 2017, Inogen, Inc. (Inogen) issued a press release
announcing the estimated impact of the 21st Century
Cures Act on its fourth quarter 2016 financial results. A copy of
the press release is furnished herewith as Exhibit 99.1.
Item 7.01. Regulation FD Disclosure
Inogens officers will participate in the J.P. Morgan
35th Annual Healthcare Conference in San Francisco on
Tuesday, January 10, 2017 beginning at 4:00pm PT, and the
19th Annual Needham Growth Conference in New York City
on Thursday, January 12, 2017 at 10:00am ET.During the
conferences and in separate sessions with analysts and investors,
our officers will refer to an updated slide presentation.A copy
of this updated slide presentation is attached hereto as Exhibit
99.2 and is incorporated herein by reference.Interested parties
can access the live audio webcast for both of these conference
presentations from the Events section of the Investor Relations
page on the Inogen website at www.inogen.com.
Item 9.01. Financial Statements and Exhibits
(d)Exhibits
|
Exhibit |
Description |
|
99.1 |
Inogen, Inc. Press Release dated January 9, 2017 |
|
99.2 |
Investor Presentation |
The information furnished to this Current Report on Form 8-K,
including Exhibit 99.1 and Exhibit 99.2 attached hereto, shall
not be deemed filed for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the Exchange Act) or otherwise
subject to the liabilities of that section, nor shall it be
deemed incorporated by reference into any other filing under the
Securities Act of 1933, as amended (the Securities Act) or the
Exchange Act, except as expressly set forth by specific reference
in such a filing.
About INOGEN, INC. (NASDAQ:INGN)
Inogen, Inc. is a medical technology company. The Company is engaged in developing, manufacturing and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company’s Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device weighing approximately 4.8 or seven pounds. Its Inogen One G2 and Inogen One G3 have approximately five and 4.5 hours of battery life, respectively, with a single battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory patient market and serves as a backup to its Inogen One system for ambulatory patients. The Company sells its products to home medical equipment providers in the United States and in foreign countries. INOGEN, INC. (NASDAQ:INGN) Recent Trading Information
INOGEN, INC. (NASDAQ:INGN) closed its last trading session down -0.53 at 65.31 with 148,901 shares trading hands.